{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:51:07Z","timestamp":1770479467126,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jaad.2005.10.058","type":"journal-article","created":{"date-parts":[[2006,2,20]],"date-time":"2006-02-20T10:57:23Z","timestamp":1140433043000},"page":"S128-S134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"S2","title":["The treatment of pyoderma gangrenosum using etanercept"],"prefix":"10.1016","volume":"54","author":[{"given":"David B.","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene T.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.10.058_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archderm.1930.01440160053009","article-title":"Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults","volume":"22","author":"Brunsting","year":"1930","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.jaad.2005.10.058_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000372-199302000-00005","article-title":"The evolution of pyoderma gangrenosum: a clinicopathologic correlation","volume":"15","author":"Hurwitz","year":"1993","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2005.10.058_bib4","first-page":"116","article-title":"Pyoderma gangrenosum","volume":"3","author":"Provost","year":"2003","journal-title":"Adv Stud Med"},{"key":"10.1016\/j.jaad.2005.10.058_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.140.7.861","article-title":"Poor prognosis of arthritis-associated pyoderma gangrenosum","volume":"140","author":"Charles","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jlb.41.3.196","article-title":"Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha","volume":"41","author":"Shalaby","year":"1987","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaad.2005.10.058_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/1523-1747.ep12471720","volume":"96","author":"Norris","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib8","series-title":"Basic and clinical immunology","year":"1994"},{"key":"10.1016\/j.jaad.2005.10.058_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archderm.134.1.62","article-title":"Cellular and molecular dynamics in exercise-induced urticarial vasculitis lesions","volume":"134","author":"Kano","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archderm.137.12.1571","article-title":"Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease)","volume":"137","author":"Voigtlander","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archderm.138.1.99","article-title":"Treatment of scleroderma","volume":"138","author":"Sapadin","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.140.5.570","article-title":"Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of Sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction","volume":"140","author":"Kawakami","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib13","first-page":"10","article-title":"AntiTNF-alpha strategy: present status of this therapeutic paradigm","volume":"36","author":"Singh","year":"2004","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2005.10.058_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1524-475X.1996.40307.x","article-title":"Biochemical analysis of acute and chronic wound environments","volume":"4","author":"Tarnuzzer","year":"1996","journal-title":"Wound Rep Reg"},{"key":"10.1016\/j.jaad.2005.10.058_bib15","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.4049\/jimmunol.171.7.3855","article-title":"Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts","volume":"171","author":"Yamane","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2005.10.058_bib16","first-page":"227","article-title":"TNF, immunity and inflammatory disease: lessons of the past decade","volume":"43","author":"Beutler","year":"1995","journal-title":"J Investig Med"},{"key":"10.1016\/j.jaad.2005.10.058_bib17","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/sj.onc.1202568","article-title":"Modulation of life and death by the TNF receptor superfamily","volume":"17","author":"Baker","year":"1998","journal-title":"Oncogene"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2005.10.058_bib18","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1186\/ar569","article-title":"Signaling for survival and apoptosis in the immune system","volume":"4","author":"Mak","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jaad.2005.10.058_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1525-1381.1999.99237.x","article-title":"Inherited variability of tumor necrosis factor production and susceptibility to infectious disease","volume":"111","author":"Knight","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.jaad.2005.10.058_bib20","series-title":"Full prescribing information","author":"Enbrel\u00ae (etanercept)","year":"2005"},{"key":"10.1016\/j.jaad.2005.10.058_bib21","first-page":"930","article-title":"Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody","volume":"137","author":"Tan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib22","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.139.12.1540","article-title":"Severe hidradenitis suppurativa treated with infliximab infusion","volume":"139","author":"Adams","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.058_bib23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archderm.139.10.1259","article-title":"Recalcitrant, recurrent aphthous stomatitis treated with etanercept","volume":"139","author":"Robinson","year":"2003","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2005.10.058_bib24","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Behcet's disease: a new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205045792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205045792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:01:55Z","timestamp":1759269715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205045792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0190962205045792"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.10.058","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The treatment of pyoderma gangrenosum using etanercept","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.10.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}